Cyclist representing return to activity after cartilage treatment

CartiHeal Agili-C · Treatment comparison

CartiHeal vs OATS osteochondral transfer

CartiHeal fills the lesion with an off-the-shelf resorbable scaffold. OATS transfers the patient’s own mature cartilage-and-bone plugs from elsewhere in the joint.

Quick answer

CartiHeal avoids an osteochondral donor site but relies on scaffold integration and remodelling. OATS transfers living cartilage and bone immediately but is constrained by graft harvest and matching. There is no direct head-to-head trial established here.

Verified across three networks

Trusted by patients on Doctify, Google and Top Doctors

What fills the lesion

Off-the-shelf scaffold and autologous graft are fundamentally different

CartiHeal uses a manufactured porous aragonite implant intended to be progressively replaced by tissue. OATS transfers one or more osteochondral plugs from a lower-load area of the patient's own joint into the defect.

OATS therefore places mature hyaline cartilage and bone immediately but creates a donor site. CartiHeal avoids graft harvest but relies on scaffold integration and biological remodelling.

CartiHeal implant placement sequence in a prepared osteochondral knee lesion
CartiHeal is off the shelf and resorbable; OATS uses living osteochondral tissue transferred within the joint.
Cylindrical osteochondral site preparation for CartiHeal
CartiHeal and OATS both require accurate osteochondral site preparation, but they fill it differently.

Technical trade-offs

Both are osteochondral operations with different constraints

Both techniques prepare cylindrical sites across cartilage and bone. OATS is constrained by available donor tissue, plug matching and donor-site effects. CartiHeal uses selected implant sizes and can use multiple plugs while preserving an appropriate bone bridge.

Lesion size, geometry, location and surrounding cartilage influence whether either approach is sensible. Larger or more complex defects can lead to other graft or cell-based options.

Evidence comparison

There is no direct CartiHeal-versus-OATS trial here

CartiHeal has five-year randomised evidence against a debridement or microfracture control arm. That study does not establish superiority over OATS.

OATS has its own evidence base and long-established indications. Comparing separate studies is less reliable than a head-to-head trial because populations, lesions and outcomes differ.

The credible choice comes from matching lesion and patient to the strengths and limitations of each operation—not declaring a universal winner.

Side-by-side

Scaffold remodelling or tissue transfer?

Question
CartiHeal
OATS
What is implanted
Porous biphasic aragonite scaffold
Patient’s own cartilage-and-bone plug
Donor site
No cartilage graft harvest
Plug harvested from a lower-load joint area
Biological strategy
Progressive resorption and tissue replacement
Immediate transfer of mature osteochondral tissue
Stages
Single-stage
Single-stage
Direct comparison
No head-to-head OATS trial established here
Has an independent evidence base
consulting-in-office-with-pen

CartiHeal and OATS questions

Is CartiHeal a synthetic version of OATS?

No. Both fill an osteochondral site, but OATS transfers the patient’s living cartilage-and-bone plug while CartiHeal uses an off-the-shelf scaffold intended to remodel.

Does CartiHeal avoid a donor site?

Yes. It does not require harvesting osteochondral plugs from another area of the joint.

Has CartiHeal been proven better than OATS?

Not by the randomised study discussed here. That trial compared CartiHeal with debridement or microfracture control, not OATS.

Can both use multiple plugs?

Both concepts can use more than one cylindrical site in selected cases, but planning, constraints and technical guidance differ.

Still have more specific concerns?

Free Discovery Call

Options that our doctors may discuss include NanoACi, ChondroFiller, Mytocel MSK, joint replacement, established conservative care or surgery, depending on examination and imaging.

Match the cartilage operation to the lesion

Professor Lee can explain current graft and restoration options and record CartiHeal interest while availability develops.

Privacy & Cookies Policy